ABL
Chirag Lodaya is a data scientist with extensive experience in the field of data analytics and machine learning, currently serving at Heyday since June 2024, focusing on the development and optimisation of supply chain components within CPG E-commerce. Previously, from October 2021 to June 2024 at antuit.ai, Chirag worked on predictive modelling for AI-powered SaaS solutions aimed at enhancing decision-making in the digital supply chain. Additionally, at Dozee, from January 2021 to September 2021, Chirag engaged in statistical and predictive modelling for health monitoring devices. Earlier experience includes a role as a Technical Solutions Engineer Associate at Akamai Technologies, where Chirag addressed complex issues related to content delivery networks. Chirag holds a Post Graduate Program in Artificial Intelligence, Machine Learning & Data Science from Texas McCombs School of Business and a Bachelor of Engineering in Electronics and Communication Engineering, along with an under graduate program in Computer Science from KLE Technological University, Hubballi.
This person is not in any offices
ABL
From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance and drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of virus vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.